Cite
HARVARD Citation
Carter, J. et al. (2017). Use of Precision Medicine Molecular Profiling of Baseline Tumor Specimen May Not Benefit Outcomes in Children With Relapsed or Refractory Pediatric Sarcomas. Clinical pharmacology & therapeutics. 101 (3), pp. 328-330. [Online].